Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe.

Aim: To investigate treatment patterns, healthcare resource utilization and disease burden in patients with multiple myeloma (MM).

Methods

Point-in-time survey of physicians and their patients presenting in a real-world clinical setting, collected across Europe between May and November 2021.

Results

In total, 173 physicians provided data for 2179 patients with MM. Treatments received became more diverse as line of therapy increased, dictated by previous treatment choices. Overall, 25% of all patients were tri-exposed, and experienced a higher degree of healthcare resource utilization, disease burden and impairment than non-tri-exposed patients.

Conclusion

The treatment landscape in MM is complex and evolving. There is an unmet need for more effective therapies to reduce disease burden, particularly in tri-exposed patients.